Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned new fundraising through debt or equity. Sanjay Shah stated that they have been exploring potential M&A opportunities regularly, but no material deals have been reached due to valuation challenges. The company remains open to acquisitions but has not identified suitable targets aligned with their business ("DNA"). No specific details or plans about raising new debt or equity capital were discussed in the current call or documents.

Any current/future capex/capital investment/strategic investment?

The company is actively exploring mergers and acquisitions (M&A) opportunities but has not reached valuation agreements yet. They are seeking targets aligned closely with their business DNA but have not materialized any deals so far. The company remains open and regularly explores strategic investments. There is no mention of specific capital expenditure plans in the current discussion. Focus seems stronger on organic growth and consolidation, particularly in insurance distribution and mutual fund verticals, rather than immediate large capital investments.

Future growth expectations in sales/revenue/volumes?

The company expects to reach ₹1 lakh Crores AUM by March 2026, up from ₹80,000 Crores currently. SIP sales/net sales are projected to grow in line with SIP book expansion, aiming for an SIP book of around ₹700 Crores by March 2024 and ₹1,000 Crores by March 2026. Net sales growth is expected at 10-12% yearly from SIPs, with a similar 10-12% growth anticipated from mark-to-market gains, depending on market conditions. Insurance business is expected to normalize in FY2024 after regulatory adjustments, resuming growth trajectory from FY2025 onwards. POS insurance channel is rapidly expand

Future growth expectations in earnings/operating earnings/profits/EPS?

Employee cost growth is expected to remain moderate, with non-sales functions stable; costs facing advisers/IFAs and branch expansion may grow (Page 14). Consolidated profit grew 25% YoY, with operating profit up 21.3% YoY (Page 5). Profit after tax grew 32-34% YoY in first 9 months, supported by treasury book growth (close to Rs. 200 Cr) (Page 5). The insurance business is normalizing with growth expected from FY2025 onwards, after a consolidation year in FY2024 (Pages 5, 13). Yield on mutual fund operations expected to settle around 87-88 basis points in FY2025, supporting stable rev

Prudent Corporate Advisory Services LtdQ3 FY24Capital Markets

Prudent Corporate Advisory Services Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,119P/E: 52.4Market Cap: ₹12.8K CrSector: Capital Markets

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

The company expects to reach ₹1 lakh Crores AUM by March 2026, up from ₹80,000 Crores currently.
SIP sales/net sales are projected to grow in line with SIP book expansion, aiming for an SIP book of around ₹700 Crores by March 2024 and ₹1,000 Crores by March 2026.
Net sales growth is expected at 10-12% yearly from SIPs, with a similar 10-12% growth anticipated from mark-to-market gains, depending on market conditions.
Insurance business is expected to normalize in FY2024 after regulatory adjustments, resuming growth trajectory from FY2025 onwards.
POS insurance channel is rapidly expanding, from 6,500 registered POS last year to over 10,000 currently; POS is expected to become the dominant distribution channel over time.
Employee costs for non-sales functions are expected to remain stable, while sales/branch expansion costs may grow but at a lower rate than revenue growth, indicating operating leverage.
The yield on mutual funds is expected to stabilize around 87-88 basis points from FY2025.

Margin guidance

Category 3

Employee cost growth is expected to remain moderate, with non-sales functions stable; costs facing advisers/IFAs and branch expansion may grow (Page 14).
Consolidated profit grew 25% YoY, with operating profit up 21.3% YoY (Page 5).
Profit after tax grew 32-34% YoY in first 9 months, supported by treasury book growth (close to Rs. 200 Cr) (Page 5).
The insurance business is normalizing with growth expected from FY2025 onwards, after a consolidation year in FY2024 (Pages 5, 13).
Yield on mutual fund operations expected to settle around 87-88 basis points in FY2025, supporting stable revenue growth (Pages 5, 10).
Operating leverage likely to benefit from topline growth of 20-22%, implying profits and EPS should grow faster than revenues (Page 14).
SIP and AUM growth remain robust; target of Rs 1 lakh Cr AUM by March 2026 supporting long-term earnings expansion (Pages 6, 8).

See what Prudent Corporate Advisory Services Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The transcript does not mention any current or planned new fundraising through debt or equity.
Sanjay Shah stated that they have been exploring potential M&A opportunities regularly, but no material deals have been reached due to valuation challenges.
The company remains open to acquisitions but has not identified suitable targets aligned with their business ("DNA").
No specific details or plans about raising new debt or equity capital were discussed in the current call or documents.

Order book

The transcript and presentation excerpts do not explicitly mention current or expected orderbook/pending orders details. However, some insights that may be relevant include: - The company's mutual fund AUM has grown significantly, targeting ₹1 lakh Crores AUM by March 2026, with current AUM around ₹77,800 Crores as of December 2023. - SIP book stands at ₹650-700 Crores as of December 2023, expected to cross ₹1,000 Crores by March 2026. - Robust inflows via SIPs and systematic transfers indicate a healthy pipeline of recurring business. - Insurance business premiums and commission income indicate ongoing and expected business growth. - No direct reference to any explicit "orderbook" or "pending orders" metrics is given. Therefore, the company's growth is more focused on AUM and mutual fund SIP inflows rather than traditional orderbook data.

See what Prudent Corporate Advisory Services Ltd management said on order book — free account, 30 seconds.

Capex plans

The company is actively exploring mergers and acquisitions (M&A) opportunities but has not reached valuation agreements yet.
They are seeking targets aligned closely with their business DNA but have not materialized any deals so far.
The company remains open and regularly explores strategic investments.
There is no mention of specific capital expenditure plans in the current discussion.
Focus seems stronger on organic growth and consolidation, particularly in insurance distribution and mutual fund verticals, rather than immediate large capital investments.

Track Prudent Corporate Advisory Services Ltd — get its next earnings analysis in your feed

How does Prudent Corporate Advisory Services Ltd rank vs peers in Capital Markets?

Pro feature

ThisPrudent Corporate Advisory Services Ltd

Rev 2Mar 3

See where Prudent Corporate Advisory Services Ltd sits in Capital MarketsSee which companies these are, and every other name in the sector.Open rankings

How does Prudent Corporate Advisory Services Ltd rank in Capital Markets?

Compare Prudent Corporate Advisory Services Ltd against every Capital Markets company (Q3 FY24) on revenue, margins and earnings-call signals.

View Capital Markets leaderboard →

What Prudent Corporate Advisory Services Ltd's management said in earlier quarters

Others in Capital Markets this season

CARE Ratings Ltd (Q1 FY25)
78.92 Crs, up 19% YoY (Page 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.
ICRA Ltd (Q3 FY25)
Q3 FY2025 Revenue: ₹120.9 crore, up 5.5% YoY from ₹114.6 crore in Q3 FY2024 (Page 6). Key concall takeaways from ICRA Ltd's Q3 FY25 earnings call — and how it…
CARE Ratings Ltd (Q3 FY26)
90.24 Crs, up 15% YoY (Page 12, 2) . Key concall takeaways from CARE Ratings Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
CARE Ratings Ltd (Q1 FY27)
111.68 Cr, up 18.9% YoY (Page 2, 13) . Key concall takeaways from CARE Ratings Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs National Stock Exchange Of India Ltd vs ICICI Prudential Asset Management Co Ltd vs BSE

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →